Mackenzie Financial Corp. today announced Mackenzie’s in-house growth investing team will assume management of Mackenzie Universal Health Sciences Capital Class on July 25.

The change is occurring one month earlier than originally stated on June 3. Mackenzie says Investors will benefit from the accelerated change, as the fund’s management fee will also be reduced by 0.25% to 2.00% on July 25.

Wendy Chua, assistant vice president, will assume lead management duties for the fund. She will be supported by Ian Ainsworth, senior vp, and Mark Grammer, vp of Mackenzie.

Chua joined Mackenzie in 2002 and since then has been responsible for analysis and research of global healthcare and biotechnology opportunities for Mackenzie Universal Future Fund, Mackenzie Universal Global Future Fund and Mackenzie Universal Emerging Technologies Capital Class.